The Cancer Trust's
DIRECTORS AND ADVISORS
Our Directors and Advisors have worked together since 2013, contributing different but very complimentary areas of expertise.
Duncan N. Darrow... a Wall Street dealmaker for over 25 years and the founder (in 2002) of what has become the nation's largest free cancer counseling center that operates on a regional basis (visit www.fightingchance.org). He is the Chairman of the Board of The Cancer Trust...
CONTRIBUTIONS: Duncan founded The Cancer Trust and is the keeper of its vision. He also is heavily involved in recruiting the research talent pools, talking to both scientists and Directors of the cancer centers where they work.
Mark Pasmantier, MD... has been a clinical oncologist for over 40 years at New York Hospital and is a member of the faculty of Weill Cornell Medical College. He is also a director of The Cancer Trust...
CONTRIBUTIONS: Mark is a builder of bridges between the sometimes different worlds of academia and commerce; He is skilled at navigating the academic bureaucracy and has deep insights into new research pathways having practiced as a clinical oncologists for decades.
Jeremy Bloomer... has led several successful startups including: an investment bank, a $1 Billion investment fund and an insurance company. He is a Director of The Cancer Trust...
CONTRIBUTIONS: Jeremy infuses the scientists who will lead research projects with an entrepreneurial spirit that is his passion and gently reminds them of business principles such as: milestones, careful budgeting and accountability.
Alan Jakimo... is a graduate of Harvard's Law School and Business School and has been a partner in Sidley Austin, where he specializes in Tech Transfer Agreements. He also is on the advisory board of the Genetics Policy Institute and Cold Spring Harbor Laboratories. He too is a director of The Cancer Trust...
CONTRIBUTIONS: lan is a interface with the Technology Transfer Officers or "TTOs" who are based at each of the Cancer Centers in the Consortium and must negotiate the contractual arrangements among those Centers and vis-a-vis the Funding Source.
Michael Meyers, MPH and Scott Gottleib, MD... are Managing Directors in the investment banking firm of T.E. Winston & Co. and have helped it achieve market leadership in financing and counseling Biotechs and Big Pharma...
CONTRIBUTIONS: Michael and Scott provide The Cancer Center with an "eco-scan" of private sector funding sources that would be drawn to a collaborative cancer research model. Then they build a bridge between the funding source and the collaborative cancer researchers; they also are responsible for development of a Term Sheet and shepherding the transaction to conclusion.
Kevin Vigilante, MD... is a Senior Vice President in the worldwide consulting firm of Booze Allen Hamilton, where he heads up its health care practice. Dr. Vigilante is widely respected for helping develop business plans for companies in the field of
biotechnology...
CONTRIBUTIONS: Kevin works with the Directors of the Cancer Centers participating in the Consortium to formulate a strategic plan and research plan that should resonate with the Funding Source.
